Berberine alleviates lipid metabolism disorders via inhibition of mitochondrial complex I in gut and liver
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 17 (7) , 1693-1707
Abstract
This study is to investigate the relationship between berberine (BBR) and mitochondrial complex I in lipid metabolism. BBR reversed high-fat diet-induced obesity, hepatic steatosis, hyperlipidemia and insulin resistance in mice. Fatty acid consumption, β-oxidation and lipogenesis were attenuated in liver after BBR treatment which may be through reduction in SCD1, FABP1, CD36 and CPT1A. BBR promoted fecal lipid excretion, which may result from the reduction in intestinal CD36 and SCD1. Moreover, BBR inhibited mitochondrial complex I-dependent oxygen consumption and ATP synthesis of liver and gut, but no impact on activities of complex II, III and IV. BBR ameliorated mitochondrial swelling, facilitated mitochondrial fusion, and reduced mtDNA and citrate synthase activity. BBR decreased the abundance and diversity of gut microbiome. However, no change in metabolism of recipient mice was observed after fecal microbiota transplantation from BBR treated mice. In primary hepatocytes, BBR and AMPK activator A769662 normalized oleic acid-induced lipid deposition. Although both the agents activated AMPK, BBR decreased oxygen consumption whereas A769662 increased it. Collectively, these findings indicated that BBR repressed complex I in gut and liver and consequently inhibited lipid metabolism which led to alleviation of obesity and fatty liver. This process was independent of intestinal bacteria.Keywords
This publication has 52 references indexed in Scilit:
- Anti-obesity drugs: past, present and futureDisease Models & Mechanisms, 2012
- TGR5 potentiates GLP-1 secretion in response to anionic exchange resinsScientific Reports, 2012
- Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic GluconeogenesisPLOS ONE, 2011
- Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic ratsMetabolism, 2011
- Integrating multiple aspects of mitochondrial dynamics in neurons: Age-related differences and dynamic changes in a chronic rotenone modelNeurobiology of Disease, 2011
- Impairing the Mitochondrial Fission and Fusion Balance: A New Mechanism of NeurodegenerationAnnals of the New York Academy of Sciences, 2008
- Efficacy of berberine in patients with type 2 diabetes mellitusMetabolism, 2008
- Berberine improves glucose metabolism through induction of glycolysisAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Mitochondrially Targeted Effects of Berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium] on K1735-M2 Mouse Melanoma Cells: Comparison with Direct Effects on Isolated Mitochondrial FractionsThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Influence of monosaccharide derivatives on liver cell glycosaminoglycan synthesis: 3-deoxy-d-xylo-hexose (3-deoxy-d-galactose) and methyl (methyl 4-chloro-4-deoxy-,β-D-galactopyranosid) uronateBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1995